INTRODUCTION
============

Mesenchymal stem cells or multipotent mesenchymal stromal cells (MSCs) comprise a promising tool for regenerative stem cell therapy due to their ability to self renew, differentiate into multiple tissues [@B1] and immunomodulatory properties [@B2]. The umbilical cord, which is discarded after birth, can provide an inexhaustible and non-controversial source of stem cells for therapy. MSCs have been isolated from different compartments of the umbilical cord, and Wharton\'s jelly (WJ) is the embryonic mucous connective tissue lying between the amniotic epithelium and the umbilical vessels. WJ-MSCs bear higher proliferation rate and self-renewal capacity than adult tissue-derived MSCs and are a primitive stromal cell population [@B3].

Stem cell niche or physiological microenvironment plays a crucial role in maintenance of stem cell properties and oxygen concentration is an important component of the stem cell niche. Low oxygen environment (hypoxia) is physiologic for most mammalian embryos and in fact, human embryonic stem cells (hESC) derived from early stage blastocysts are also exposed to the low oxygen environment *in vivo.* Hypoxia has been shown to maintain hESC pluripotency and minimize spontaneous differentiation [@B4], [@B5]. Although, MSCs are typically cultured at 21% oxygen under *in vitro* conditions, physiological niches of MSCs have much lower oxygen tension than ambient [@B6]. There is a probable link between hypoxia and maintenance of stemness and hence, oxygen tension in the microenvironment of MSCs might play a crucial regulatory role in the maintenance of stem cell properties.

It has been reported that hypoxia requires notch signaling to maintain undifferentiated cell state. Notch signaling controls cell fate choices [@B7]. Notch signaling normally inhibits differentiation and maintains cells in progenitor state. The effects of hypoxia are directly regulated by a transcription factor, hypoxia-inducible factor (HIF) [@B8], [@B9]. Notch intracellular domain interacts with HIF-1α which is recruited to Notch-responsive promoters upon Notch activation under hypoxic conditions, suggesting cross-talk between HIF and Notch signaling pathways [@B10].

Presence of hypoxia is also associated with certain pathological conditions such as the formation and growth of tumors [@B11], wounding [@B12], arthritic joints [@B13] and ischemic heart disease [@B14]. It has been shown that MSCs and progenitor cells, on transplantation, home specifically to hypoxic events *in vivo* and function as therapeutic agents. MSCs from bone marrow have been reported to induce neovascularization in myocardial infarction and critical limb ischemia [@B15], [@B16]. In the ischemic tissues, MSCs experience severe low oxygen conditions. In order for the MSCs to adapt to low oxygen, they must be able to sense and respond accordingly to the change in oxygen level. For therapeutic applications, it is important to generate MSCs which can adapt to the *in vivo* environment while retaining immunosuppressive properties, stem cell characteristics and multilineage differentiation potential.

Not much has been reported regarding the effect of hypoxia on WJ-MSC characteristics, though hypoxia does prevail in the mammalian reproductive tract and intrauterine oxygen tension is known to be 2% [@B6]. Hypoxia can influence proliferation and differentiation of various stem/precursor cell populations [@B17], [@B18]. There are contradictory reports regarding the effect of hypoxia on self-renewal and differentiation potential of MSCs from other sources [@B19], [@B20]. Therefore, in this study we investigated the effect of relatively long-term low oxygen tension on proliferative capacity, multi-lineage differentiation potential and immunophenotypic characteristics of WJ-MSCs. We also investigated the expression levels of some of the notch pathway and its downstream target genes in WJ-MSCs in response to hypoxia. Hypoxia and HIFs are known to play a role in tumor progression and therefore we analyzed the expression of several DNA repair and transformation markers in hypoxic WJ-MSCs. Oxygen works as a signaling molecule and hypoxia can induce differentiation towards certain cell types [@B21], [@B22]. Here we analyzed the transcriptional changes with respect to stem cell specific markers and lineage differentiation genes on exposing WJ-MSCs to hypoxia as compared to normoxia. The purpose is to understand if hypoxic environment can influence WJ-MSCs towards adoption of a particular fate or a particular lineage. This information would be especially useful from a clinical point of view, if WJ-MSCs are used as a therapeutic tool to repair tissue injuries where they would encounter severe low oxygen tension.

MATERIALS & METHODS
===================

Isolation and culture of WJ-MSCs
--------------------------------

Human umbilical cords (n=10) from both sexes were collected from full-term births after either cesarean section or normal vaginal delivery with informed consent using the guidelines approved by the Institutional Committee for Stem Cell Research and Therapy (ICSCRT) and Institutional Ethics Committee (IEC) at the Manipal Hospital, Bangalore, India. MSCs, from WJ of umbilical cord, were isolated as previously described [@B23]. After the enzymatic treatment, cells were suspended in 10% FBS (Hyclone, Victoria, Australia) and Knock out Dulbecco\'s modified Eagle\'s medium (DMEM-KO) (Invitrogen, CA, USA) and plated on tissue culture plastic plates (Falcon, Becton, Dickinson, and Company, NJ, USA). WJ-MSCs were cultured in DMEM-KO with 4,500 mg/ml glucose and 2mM L-glutamine (Invitrogen), supplemented with 10% FBS (Hyclone, cat.no.SH30084.03, Lot no.GQM0049). All cultures were plated at a density of 5000 cells/cm^2^ and passaged when they reached 70-80% confluence. For normoxic studies, WJ-MSCs were cultured at 95% air (21% O~2~) - 5% CO~2~. Hypoxia (2-3% oxygen) was achieved using a tri-gas incubator (HERA cell 240, Thermo Scientific, MA, USA) that was flushed with humidified gas mixtures of composition 2% O~2~- 5% CO~2~- 93% N~2.~.

Two random fields each from three to five biological replicates of hypoxic and normoxic WJ-MSCs were used to measure cell area via Image-Pro AMS version 6.0 software (Media Cybernetics, Inc, Silver Spring, MD, USA) using bright field images.

Growth Kinetics
---------------

WJ-MSCs were plated at passage 1 into two sets: one set was cultured under normoxic conditions and the other under hypoxic conditions. Cells in respective culture conditions were maintained till passage 9-11 and cell numbers were determined at the end of each passage. The total number of cells at each passage was calculated as a ratio of total number of cells harvested to total number of cells seeded multiplied by the total number of cells from the previous passage. Population doublings were calculated using the formula: X = \[log10(NH)- log10(NI)\]/log10(2) where NI is the inoculum cell number and NH the cell harvest number. To yield the cumulated doubling level, the population doubling for each passage was calculated and then added to the population doubling levels of the previous passages.

The population doubling time was obtained by the formula: TD=tplg2/ (lgNH-lgNI). NI:the inoculum cell number; NH is the cell harvest number and t is the time of the culture (in hours). The mean and standard deviation were calculated for three independent experiments. Statistical analysis was carried out using a *t*test. P values \<0.05 were considered significant.

Senescence assay
----------------

Senescence assay was performed with WJ-MSC cultures using Senescence β-Galactosidase Staining kit (Cell Signaling Technologies, Danvers, MA, USA,) according to the manufacturer\'s protocol. Cells were observed for development of blue color under a microscope using 10X objective (Nikon, Tokyo, Japan).

Immunophenotyping
-----------------

WJ-MSCs cultured in normoxia and hypoxia were taken for flow cytometric analysis at passage 9-11. The following antibodies were used to mark the cell surface epitopes- CD90-PE, CD44-PE, CD73-PE, CD166-PE, CD34-PE and CD45-FITC (all from BD Pharmingen, CA, USA), CD105-PE (R&D Systems Inc, MN, USA,), and HLA-DR-FITC (BD Biosciences). All analyses were standardized against negative control cells incubated with isotype-specific IgG1-PE and IgG1-FITC (BD Pharmingen). The number of cells staining positive for a marker was determined by the percentage of cells present within a gate established such that 3% of the positive events measured represented nonspecific binding by the PE or FITC- conjugated isotype-matched control. At least 10,000 events were acquired on BD LSR II flow cytometer and the results were analyzed using WIN MDI v2.8 software.

Differentiation
---------------

Osteogenic and adipogenic differentiation potential of WJ-MSCs, when cultured under hypoxia and normoxia, was examined using standard protocols [@B23]. Chondrogenic differentiation was induced in confluent monolayer cultures of WJ-MSCs, cultured under normoxia and hypoxia, using STEMPRO Chondrogenesis Differentiation Kit (Invitrogen). Differentiated cells were stained with Alcian blue 8GX between 14-17 days (Sigma, St Louis, MO, USA). Images were captured using Nikon microscope (Nikon, Tokyo, Japan).

Reverse Transcription-Polymerase Chain Reaction Analysis (RT-PCR)
-----------------------------------------------------------------

WJ-MSCs were exposed to normoxia and hypoxia for the specified time intervals, RNA was extracted and RT-PCR performed as described [@B23] using primer sequences listed in table [1](#T1){ref-type="table"}.

Karyotype Analysis
------------------

Karyotyping of WJ-MSCs cultured under normoxia and hypoxia was performed at passage 10-11 using standard Giemsa staining procedure. Images were acquired using Nikon-Eclipse-90*i* microscope (Nikon).

Taqman low density arrays
-------------------------

The Human Stem Cell Pluripotency Array (Applied Biosystems), containing a well-defined set of validated gene expression markers to characterize undifferentiated stem cells and early differentiation lineage markers, was used. The 384 wells of each Human stem cell pluripotency array card were preloaded with fluorogenic probes and primers (Applied Biosystems). cDNAs were loaded on the microfluidic cards for thermal cycling on an ABI PRISM 7900HT Sequence Detection System (Applied Biosystems). Expression values for target genes were normalized to the expression of 18s rRNA. Transcriptional analysis was performed with WJ-MSCs at passage 11. For data analysis, the ABI PRISM 7900HT Sequence Detection System software (SDS 2.1 software) calculated the levels of target (WJ-MSC) gene expression in hypoxic samples relative to the level of expression in normoxia. A cut off cycle threshold value of 35.0 was arbitrarily assigned. *Samples* with a *cycle threshold* of 35 or less were considered for calculating the fold change in expression.

RT-PCR validation of array data
-------------------------------

To confirm the gene expression profile obtained by TLDA, a number of select genes were subjected to quantitative and semi-quantitative RT-PCR analysis. Quantitative amplifications were carried out in duplicate using SYBR green master mix (Applied Biosystems). PCR reactions were run on an ABI Prism 7500HT (Applied Biosystems) and SDS v2.1 software was used to analyze the results. All measurements were normalized by 18s rRNA. Semi-quantitative RT-PCR products were resolved on 1.5-2% agarose gel and the band densities were quantitated using the GeneTools software (Syngene, Cam-bridge, UK). The primer sequences used in RT-PCR analysis and amplicon size are listed in Table [1](#T1){ref-type="table"}.

Statistical data analysis
-------------------------

Data were presented as means ± standard error mean. Statistical comparisons were performed using either the student\'s two-tailed *t*-test (unpaired/paired) or the Wilcoxon matched pairs test as appropriate according to data distribution. *P* values \<0.05 were considered significant. Data analysis and graphical representations were performed by using GraphPad Prism 5 software (GraphPad, San Diego, CA, USA).

RESULTS
=======

Proliferative response of WJ-MSCs under hypoxic conditions
----------------------------------------------------------

Effect of low oxygen tension on proliferative capacity of WJ-MSCs has not yet been demonstrated. We found that WJ-MSCs cultured under hypoxic conditions grew at faster rates and yielded higher total cell numbers as compared to WJ-MSCs cultured at 21% O~2.~ WJ-MSCs cultured under hypoxia resulted in maximal cell numbers 1.87 x 10^10^±8.9 x 10^9^while normoxic cultures resulted in 1.46 x 10^9^±5.49 x 10^8^cells (*p*=0.17) at the end of ten passages. Again, under hypoxia, WJ-MSCs displayed higher cumulative population doublings as compared to those cultured under normoxia with a peak of 17.8±1.2 and 14.6±0.8 respectively, at passage 10, *p* value \< 0.05 (Fig. [1](#F1){ref-type="fig"}B). The mean population doubling time of WJ-MSCs cultured under hypoxia was 28.7±1.9 h while that for normoxic cultures was 36.0±3.3 h (*p*=0.02), as shown in Fig. [1](#F1){ref-type="fig"}C.

To assess the effect of hypoxia on the morphology of WJ-MSCs, which typically demonstrated a fibroblast-like appearance (Fig. [S1](#FS1){ref-type="fig"} M and N), cell size was measured at early (P2-P5) and late (P10) passages and a size histogram was plotted for the hypoxic and normoxic cell populations. Cells were categorized according to their size and the proportion of large flattened cells, area between 2000-4000 um^2^, was greater under hypoxic conditions both at early and late passages (Fig. [1](#F1){ref-type="fig"}E) as compared to normoxic cells though the difference was not significant.

Since MSCs possess a limited lifespan during *in vitro* culture, they finally undergo replicative senescence [@B24]. Senescence is characterized by cell cycle arrest, telomere shortening and altered morphology. We have employed the enzyme lysosomal pH6 β-galactosidase as a senescence marker but did not detect much of senescence associated β-galactosidase (SA- β-gal) staining in normoxic or hypoxic cultures of WJ-MSCs till passage 10 (Fig. [1](#F1){ref-type="fig"}D).

Differentiation capacity under hypoxic conditions
-------------------------------------------------

To explore the influence of extended period of hypoxia on multi-lineage differentiation potential of WJ-MSCs, adipogenic, osteogenic and chondrogenic differentiation was induced at 21% and 2% oxygen. Oil Red O staining showed that both hypoxic and normoxic WJ-MSCs were positive for staining of neutral lipid vacuoles (Fig. [S1](#FS1){ref-type="fig"} B and C). Similarly, VonKossa assays showed mineralized deposits in osteo-induced cultures of WJ-MSCs under both hypoxia and normoxia (Fig. [S1](#FS1){ref-type="fig"} E and F). In an attempt to quantitate osteogenic differentiation, the percentage of mineral deposit area was calculated and were 10.8%±7.8% and 11.2%±5.7% for hypoxic and normoxic WJ-MSC respectively. No significant difference was found. Hypoxic WJ-MSCs retained the ability to differentiate to chondrocytes as shown by Alcian blue staining with no detectable difference between the two populations (Fig. [S1](#FS1){ref-type="fig"} H and I). Hence, even under hypoxia, WJ-MSCs retained their potential to differentiate *in vitro* towards osteogenic, chondrogenic and adipogenic lineages.

Surface phenotype characterization
----------------------------------

Flow cytometry analysis showed that when cultured under normoxia and hypoxia for ten passages, WJ-MSCs were positive for the MSC markers CD44, CD73, CD90 CD105 and CD166 and negative for CD45, CD34 and HLA-DR and no significant difference was seen in the surface marker expression level between the two populations (Fig. [2](#F2){ref-type="fig"}).

Upregulation of HIF-1α and Notch signaling pathway genes in WJ-MSCs cultured in hypoxic conditions
--------------------------------------------------------------------------------------------------

To test if there is any link between hypoxia and notch signaling in WJ-MSCs, changes in expression of HIF-1α and notch pathway genes at early period of hypoxia were investigated (Fig. [4](#F4){ref-type="fig"}A). Hypoxia led to increased HIF-1α and HIF-2α mRNA levels within 48 hours of exposure of WJ-MSCs to 2-3% oxygen. There was also an increase in the mRNA expression levels of some components of the Notch signaling pathway genes like the Notch receptors, NOTCH1 and NOTCH2 and Notch ligand JAGGED1. Under hypoxia, in four out of six samples, there was an upregulation of these genes as compared to normoxia, while in remaining samples the expression levels were comparable between hypoxia and normoxia. Hypoxia was found to alter the expression of Notch immediate downstream gene, HES1 as there was an increase in mRNA level after 48 hrs of hypoxic treatment as compared to normoxia. Our finding is consistent with previous reports suggesting a link between hypoxia and notch signaling pathway and hypoxia mediated activation of Notch signaling pathway [@B25]. To study the effect of long term hypoxia on the notch signaling pathway genes, we subjected WJ-MSCs to hypoxia for ten passages with normoxic WJ-MSCs as control (Fig. [4](#F4){ref-type="fig"}A). Even after culturing for ten passages, hypoxic WJ-MSCs maintained an increased expression of HIF1α, HIF2α, NOTCH2 and JAGGED1 as compared to normoxic WJ-MSCs. Though, the difference in expression level between the two populations was less as compared to that after 48 hr exposure. At passage 10, HES1 expression was faint in both hypoxic and normoxic WJ-MSCs with no difference being detected between the two populations while NOTCH1 was undetectable in both populations.

Karyotype analysis and transformation markers
---------------------------------------------

Since adult stem cells are evaluated for various therapeutic approaches, their biosafety criteria need to be addressed. It is reported that MSCs in long term cultures immortalize at high frequency and undergo spontaneous transformation [@B26]. Again, hypoxia has received considerable attention as an inducer of tumor metastasis. Therefore, we analyzed expression at the mRNA level of some transformation markers such as DNA-repair enzymes, RAD51, ERCC3, XRCC4, oncogene c-Myc and tumour suppressor genes p16, p21 and p53 in our WJ-MSCs, when cultured under hypoxia and normoxia for ten passages. An increase in the expression level was observed for most of these markers under hypoxic conditions when compared to normoxia (Fig. [3](#F3){ref-type="fig"}A & B). But the difference was not statistically significant. There was variation between the different hypoxic samples with respect to levels of expression of these genes. This suggests that care needs to be taken, from the point of bio safety, for every single MSC preparation cultured under hypoxia before they are planned for clinical applications.

The hypoxic WJ-MSCs maintained a normal karyotype though. To evaluate numerical and structural chromosomal abnormalities in WJ-MSCs cultured under hypoxic conditions, samples were GTG- banded. Both the populations of WJ-MSCx, cultured under hypoxia and normoxia, had normal 2n karyotype up till ten passages (Fig. [3](#F3){ref-type="fig"}C).

Functional classification of stem cell and early lineage genes upregulated in WJ-MSC under hypoxia
--------------------------------------------------------------------------------------------------

Hypoxia is understood to be a potent differentiation inducer of numerous cell types and a stimulus of gene expression. Hypoxia is known to support faster proliferation and maintenance of undifferentiated characteristics in MSCs. Hence, we investigated the gene expression profile of the hypoxia response in WJ-MSCs with respect to stemness markers and early lineage differentiation genes. We used a Human Stem Cell Pluripotency Low Density Array to investigate the difference in gene expression profile between WJ-MSCs cultured in hypoxia and normoxia. The array includes pluripotent/stem cell markers used to characterize undifferentiated stem cells and also some early differentiation lineage markers. Low density arrays allow multiple genes to be studied from a single sample. In order to evaluate the transcriptional changes between the WJ-MSCs cultured under hypoxia and normoxia, we focused on genes which have \>1.5 fold change. The results demonstrated that there was an up-regulation in stem cell markers such as CRABP2, DNMT3B, GRB7, IFITM1, KIT, LIN28, IMP2 and IL6ST in WJ-MSCs cultured under hypoxia as compared to WJ-MSCs cultured in normoxia for ten passages. A few other genes, up-regulated under hypoxia as compared to normoxia, such as NOGGIN, RUNX2, DES, COL1A and ACTC belonged to mesoderm lineage. CD34 and FLT1, both endothelial markers, were also up-regulated under hypoxic culture conditions. A few endodermal genes such as FN1, GATA6 and LAMC1 showed increased expression under hypoxia as compared to normoxia while there was a strong down regulation of a definitive endoderm gene SOX17 under hypoxia (Table [2](#T2){ref-type="table"}).

Quantitative and semi-quantitative RT-PCR, with pooled cDNA samples used in the array, was carried out to verify the fidelity of the array data where select genes expressed in accordance with their differential expression pattern in the array (Fig. [4](#F4){ref-type="fig"}B-G). There was good agreement between expression by RT-PCR and the array data. Some variation in the Ct values or fold change in expression could be due to Taqman chemistry and ABI 7900 HT instrument being used for the PCR array while the validation experiments were carried out using SYBR green reagent and ABI 7500HT instrument.

DISCUSSION
==========

Potential for self-renewal and multilineage differentiation makes MSCs an attractive therapeutic tool. WJ-MSCs from the umbilical cord are of epiblast origin [@B27] and possess multipotent properties between embryonic stem cells and adult stem cells. They have higher proliferation rates and lower tendency to differentiate to adipocytes as compared to bone marrow MSCs [@B3], [@B28]. Moreover, WJ-MSCs can replicate through many passages without karyotypic changes or senescence and can retain stemness properties for a long time in vitro [@B29]. They are similar to bone marrow stromal and other MSCs in their surface marker expression since WJ-MSCs too are positive for CD 10, CD 13, CD 29, CD 44, CD 73, CD 90, CD 105 and negative for CD 34, CD 45, CD 14, CD 33 and HLA-DR [@B3]. Stem cell niche plays a prominent role in stem cell fate determination and oxygen concentration is an important component of the stem cell niche. Low oxygen tension or hypoxia plays an important role in maintaining the plasticity and proliferation of stem cells. We demonstrate here that under hypoxia WJ-MSCs show higher proliferation, evident from the cumulative population doublings, and shorter mean population doubling time as compared to normoxic WJ-MSCs. This finding is consistent with previous reports which demonstrated enhanced proliferation of bone marrow-derived MSCs (BM-MSCs) under hypoxic conditions [@B30], [@B31]. Another study reported differential gene expression between freshly isolated MNCs and their cultured MSC subpopulation, in response to hypoxia, with upregulation of several genes involved in cell proliferation and survival in MSCs [@B32]. Based on senescence associated β-gal staining, very few senescent cells could be found even after culturing WJ-MSCs for ten passages under hypoxia, though morphology changes were noted. WJ-MSC cultures under hypoxia exhibited a higher proportion of large, flattened cells both at early and late passages as compared to normoxic cultures. The enlargement in cell size under hypoxia could be due to a natural response to low oxygen, where an increased surface area would allow for an increase in oxygen diffusion rate. Flow cytometry analysis of MSC-specific surface marker expression showed that when cultured under both experimental conditions of hypoxia and normoxia for ten passages, WJ-MSCs were positive for CD44, CD73, CD90, CD105 and CD166 and negative for CD34, CD45 and HLA-DR and no significant difference was detected between the two populations. Also, under both experimental conditions of hypoxia and normoxia, WJ-MSCs maintained their multilineage differentiation potential *in vitro*.

Transcriptional responses to hypoxia are mediated by HIFs [@B33], and there was an increase in the mRNA expression levels of HIF-1α and HIF-2α in hypoxic WJ-MSCs. The expression levels of Notch receptors NOTCH1 and NOTCH2, Notch ligand JAGGED1 and Notch downstream gene HES1 also were elevated in WJ-MSCs cultured under hypoxia as compared to normoxic WJ-MSCs. Our finding is consistent with previous reports suggesting a link between hypoxia and notch signaling pathway and hypoxia mediated activation of Notch signaling pathway [@B10], [@B25]. Notch is known to influence proliferation and hence this could also explain the increased proliferation that we observed in the hypoxic WJ-MSCs.

The presence of hypoxic condition in human tumors is well known. HIF levels are found to be elevated in a variety of cancers [@B34], [@B35]. Again, MSCs after prolonged *in vitro* culture or under stressful conditions can undergo spontaneous transformation [@B26]. After culturing the WJ-MSCs for ten passages under conditions of hypoxia and normoxia, we analyzed them by RT-PCR for certain transformation markers such as DNA repair, tumor suppressors and oncogenes. In a few of the hypoxic WJ-MSC samples, we found an upregulation for some of these markers though we did not detect statistically significant changes for any of these genes between normoxia and hypoxia. The hypoxic WJ-MSCs maintained a normal karyotype though. This suggests that care needs to be taken, from the point of bio safety, for every single MSC preparation cultured under hypoxia before they are planned for clinical applications.

MSCs have been reported to home specifically to hypoxic events *in vivo*following transplantations. As hypoxia mimicks the ischemic environment *in vitro*, from a clinical point of view, we wanted to investigate the changes in the expression profile of stem cell markers and early development lineage genes in WJ-MSCs when exposed to low oxygen environment. Using a low density PCR array for stem cell and early lineage markers, we found a higher expression of several stem cell markers such as CRABP2, DNMT3B, GRB7, IFITM1, KIT, LIN28, IMP2 and IL6ST under hypoxia as compared to normoxia. This is in agreement with reports from other groups suggesting that oxygen concentration plays a role in maintaining the plasticity of stem cells [@B6]. Notch maintains cells in a progenitor state and thus, there could be a possible link between the activation of notch pathway and the upregulation of these stem cell markers that we observe in WJ-MSCs when exposed to hypoxia.

Mesodermal/endothelial genes such as NOGGIN, RUNX2, DESMIN, COL1A, FLT1, CD34 and ACTC were also up-regulated in WJ-MSCs in response to hypoxia. In support for our finding, there are a number of reports in literature confirming hypoxia-driven neo-vascularisation and angiogenesis of MSCs [@B36], [@B37]. Recently, an up regulation in FLT1 expression in umbilical cord blood derived-MSCs under hypoxia has been demonstrated [@B38]. Another set of up-regulated genes in hypoxic WJ-MSCs were the endodermal markers FN1, GATA6 and LAMC1. GATA6, again, has been shown to play a role in vascular smooth muscle differentiation [@B39] while reports suggest that hypoxic stress up regulates fibronectin mRNA in early placenta [@B40].

Thus, to conclude, different cells of the human body are exposed to and function in different microenvironments. All mammalian cells do not respond to hypoxia in an identical manner and also they differ in their sensitivity towards hypoxia. We found that in response to chronic hypoxia for up to ten passages, WJ-MSCs from umbilical cord exhibited increased proliferative potential while maintaining immunophenotypic characteristics and *in vitro* differentiation capacity. Transcriptional profiling identified several mesodermal/endothelial genes upregulated under hypoxia, as opposed to normoxia, in WJ-MSCs suggesting that hypoxic culture condition leads to different developmental outcomes or differently committed cells. To our knowledge, this is the first report of the effect of hypoxia on growth characteristics and gene expression of WJ-derived MSCs.

Earlier we reported higher expression levels of many early endodermal markers, including SOX17, in WJ-MSCs as compared to bone marrow-derived MSCs [@B23]. Here we noticed a sharp downregulation of SOX17 along with upregulation of mesoderm lineage markers in WJ-MSCs under hypoxia. This indicates that modulation of culture conditions can be used to generate tailor-made MSCs, suitable for different therapeutic applications. Thus, WJ-MSCs when exposed to hypoxia *in vitro* or *in vivo*, could find a therapeutic role in ischemic tissues or muscle degenerative disorders. Additional *in vitro* differentiation experiments or *in vivo* studies are needed to support the above.
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![Growth kinetics and senescence in WJ-MSCs cultured under normoxia and hypoxia. (A) Growth curves of WJ-MSCs cultured under normoxia and hypoxia are demonstrated (B) Comparison of cumulative population doubling (PD) at each passage between different culture conditions: Normoxia and Hypoxia. Significant differences were observed between normoxia and hypoxia at later passages (p \< 0.05). (C) Analysis of mean PD time in hour±SEM of WJ MSCs cultured under hypoxia and normoxia. (D) Senescence associated β- galactosidase staining of WJ-MSCs at passage 10 under normoxia and hypoxia. (E) Histogram of WJ-MSC area when cultured under hypoxia and normoxia at early (P2-P5) and late passages (P10). Area of individual cells was quantified via automated image analysis from bright-field images. Results represent the average of at least three culture replicates (n=3) with SEM. Scale bar=50µm. Abbreviation: WJ-MSCs, Wharton\'s jelly-derived mesenchymal stem cells; SEM- standard error mean.](ijbsv06p0499g01){#F1}

![Morphology and multilineage differentiation potential of WJ-MSCs cultured under hypoxic and normoxic condition till late passages. WJ-MSCs (P10-P13) were investigated for *in vitro* multilineage differentiation capacity when cultured under hypoxia and normoxia. Adipogenesis was confirmed by neutral oil droplet formation stained with Oil Red O at day 18 (B & C). Formation of mineralized matrix was detected by von Kossa staining at day 21 (E & F). Chondrogenic differentiation (n=2) was demonstrated by Alcian blue staining (H & I), 4x objective. Phase contrast images of adipogenesis (J), osteogenesis (K) and chondrogenesis (L). Non-induced control cultures in growth medium without adipogenic (A), osteogenic (D) or chondrogenic differentiation (G) stimuli are shown. Morphology of WJ-MSCs, cultured under normoxia and hypoxia, as observed at passage 9 (M & N). Representative results of three independent experiments are shown. Abbreviation: WJ-MSCs- Wharton\'s Jelly derived mesenchymal stem cells. (Scale bar for A, B, C =25µm; D-F and J-N=50µm).](ijbsv06p0499g02){#FS1}

![Detection of surface marker expression of WJ-MSCs cultured under hypoxia and normoxia by flow cytometry analysis. WJ-MSCs were cultured for ten passages under hypoxia and normoxia, labeled with the indicated antibodies and analyzed by flow cytometry. An open area represents an antibody isotype control for background fluorescence and a shaded area shows signal from MSC surface marker antibodies. Representative histograms are depicted. Abbreviations: WJ-MSC- Wharton\'s Jelly derived mesenchymal stem cells.](ijbsv06p0499g03){#F2}

![Karyotype and RT-PCR analysis of transformation markers and notch pathway genes and validation of array data for WJ-MSCs cultured under hypoxia and normoxia. (A) Reverse transcription polymerase chain reaction (RT-PCR) analysis of DNA repair, tumor suppressor and oncogenes of WJ-MSCs cultured under hypoxic and normoxic conditions for 10 passages. Expression of genes RAD51, ERCC3, XRCC4, p21 and p53 were analyzed by real-time RT-PCR using SYBR green reagent and values are normalised to expression of 18s ribosomal RNA. Bars represent the mean ± SE of the ratio of message expressed under hypoxia as compared to that under normoxia for three independent experiments performed in duplicate. (B) Expression p16 and c-Myc using semi-quantitative RT-PCR. Band densities were quantified and plotted. (C) Karyotype analysis of WJ-MSCs using standard Giemsa-banding procedure represents Normal 46, XY karyotype of WJ-MSCs cultured under hypoxic and normoxic conditions. A representative analysis of three independent experiments is shown (E) Abbreviations: WJ-MSCs - Wharton\'s Jelly derived mesenchymal stem cells; SE- standard error.](ijbsv06p0499g04){#F3}

![(A) RT-PCR based comparison of HIFs and Notch pathway genes expressed by WJ-MSCs when exposed to hypoxia, with normoxia as control, for 48 hrs and for ten passages. Results are representative of at least three independent experiments. RT-PCR analysis of select differentially expressed genes to validate PCR array data. cDNA was pooled from three different samples each of hypoxic and normoxic WJ-MSCs at passage 11. (B-E) Expression of FLT1, DESMIN, IFITM1 and OCT4 was analyzed by real-time PCR using SYBR green reagent and values were normalized to 18s rRNA. (F & G) Semi-quantitative RT-PCR analysis of GATA6 and SOX17 with intensity of each band being measured by densitometry and plotted. 18S ribosomal RNA was used as an internal control for all semi-quantitative RT-PCRs. Abbreviations: WJ-MSCs - Wharton\'s Jelly derived mesenchymal stem cells; SE- standard error.](ijbsv06p0499g05){#F4}

###### 

Primer sequence used for semi-quantitative RT-PCR analysis.

  GENE       FORWARD PRIMER                REVERSE PRIMER                PRODUCT SIZE (bp)
  ---------- ----------------------------- ----------------------------- -------------------
  18s        CGGCTACCACATCCAAGGAA          GCTGGAATTACCGCGGCT            186
  CD34       AATGAGGCCACAACAAACATCACA      CTGTCCTTCTTAACCTCCGCACAGC     380
  c-MYC      AAGACTCCAGCGCCTTCTCTC         GTTTTCCAACTCCGGGATCTG         526
  DESMIN     CCAACAAGAACAACGACG            TGGTATGGACCTCAGAACC           407
  ERCC3      CCAGGAAGCGGCACTATGAGG         GGTCGTCCTTCAGCGGCATTT         171
  FLT 1      CGTAGAGATGTACAGTGAAA          GGTGTGCTTATTTGGACATC          305
  GATA 6     GCCTCACTCCACTCGTGTCT          TCAGATCAGCCACACAATATGA        546
  HES 1      CCAGTTTGCTTTCCTCATTCC         TCTTCTCTCCCAGTATTCAAGTTCC     253
  HIF-1α     CCTGCACTCAATCAAGAAGTTGC       TTCCTGCTCTGTTTGGTGAGGCT       618
  HIF-2α     AGGGGACGGTCATCTACAACC         ATGGCCTTGCCATAGGCTGAG         327
  IFITM 1    CCCCAAAGCCAGAAGATGCACAAGGAG   CGTCGCCAACCATCTTCCTGTCCCTAG   229
  JAGGED 1   AGTCACTGGCACGGTTGTAG          TCGCTGTATCTGTCCACCTG          226
  NOTCH 1    GACATCACGGATCATATGGA          CTCGCATTGACCATTCAAAC          665
  NOTCH 2    CCAGAATGGAGGTTCCTGTA          GTACCCAGGCCATCAACACA          377
  p16        TTATTTGAGCTTTGGTTCTG          CCGGCT TTCGTAGTTTTCAT         354
  p21        GAGGCCGGGATGAGTTGGGAGGAG      CAGCCGGCGTTTGGAGTGGTAGAA      220
  p53        TTGGATCCATGTTTTGCCAACTGGCC    TTGAATTCAGGCTCCCCTTTCTTGCG    488
  RAD51      TTTGGAGAATTCCGAACTGG          AGGAAGACAGGGAGAGTCG           588
  SOX 17     CGCACGGAATTTGAACAGTA          GGATCAGGGACCTGTCACAC          181
  XRCC4      AAGATGTCTCATTCAGACTTG         CCGCTTATAAAGATCAGTCTC         233

###### 

Comparison of transcription profile of stem cell and early lineage differentiation genes of Wharton\'s Jelly-derived mesenchymal stem cells cultured under hypoxic and normoxic conditions. cDNA from four different samples (n=4) at passage 11 were pooled before being used in the array. Genes with \> 1.5 fold change in expression are shown.

  No.    Gene Symbol   Gene Name                                                                                                  Description            Fold change (Normoxia=1)
  ------ ------------- ---------------------------------------------------------------------------------------------------------- ---------------------- --------------------------
  1\.    ACTC          actin, alpha, cardiac muscle 1                                                                             Cardiac/mesoderm       5.6
  2\.    CD34          CD34 molecule                                                                                              Endothelial            8.0
  3\.    CGB           chorionic gonadotropin, beta polypeptide                                                                   Trophoblast            2.8
  4\.    COL1A         collagen, type I, alpha 1                                                                                  Bone/mesoderm          2.15
  5\.    CRABP2        cellular retinoic acid binding protein 2                                                                   Stem cell              2.18
  6\.    DES           Desmin                                                                                                     Muscle/mesoderm        9.7
  7\.    DNMT3B        DNA (cytosine-5-)-methyltransferase 3 beta                                                                 Stem cell              2.04
  8\.    FLT1          fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor)   Endothelial/endoderm   2.12
  9\.    FN1           fibronectin 1                                                                                              Endoderm               1.6
  10\.   GATA4         GATA binding protein 4                                                                                     Endoderm               0.57
  10\.   GATA6         GATA binding protein 6                                                                                     Endoderm               2.15
  11\.   GRB7          growth factor receptor-bound protein 7                                                                     Stem cell              2.8
  12\.   IFITM1        interferon induced transmembrane protein 1 (9-27)                                                          Stem cell              9.3
  13\.   IL6ST         interleukin 6 signal transducer (gp130, oncostatin M receptor)                                             Stem cell              1.7
  14\.   IMP2          insulin-like growth factor 2 mRNA binding protein 2                                                        Stem cell              1.7
  15\.   KIT           v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog                                              Stem cell              2.05
  16\.   LAMC1         laminin, gamma 1 (formerly LAMB2)                                                                          Endoderm               1.6
  17\.   LIN28         lin-28 homolog (C. elegans)                                                                                Stem cell              2.0
  18\.   NOG           Noggin                                                                                                     Mesoderm               2.8
  19\.   NR6A1         nuclear receptor subfamily 6, group A, member 1                                                            Stem cell              1.6
  20\.   POU5F1        POU domain, class 5, transcription factor 1                                                                Stem cell              0.34
  20\.   RUNX2         runt-related transcription factor 2                                                                        Bone/mesoderm          1.67
  21\.   SERPINA1      Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1                        Endoderm               1.54
  22\.   SOX17         SRY (sex determining region Y)-box 17                                                                      Endoderm               0.07
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